562 results
-
List item
Withdrawn application: Pioglitazone Teva Generics
pioglitazone, date of withdrawal: 26/01/2012, Initial authorisation, Last updated: 03/07/2012Pioglitazone Teva Generics: Withdrawn applicati … authorisation) Pioglitazone Teva Generics pioglitazone On … medicinal product Pioglitazone Teva Generics 15, 30, 45 mg tablet … -
List item
Withdrawn application: Clopidogrel Teva Pharma
clopidogrel, date of withdrawal: 22/04/2009, Initial authorisation, Last updated: 23/04/2009Clopidogrel Teva Pharma: Withdrawn application … application for Clopidogrel Teva Pharma clopidogrel … clopidogrel On 22 April 2009, Teva Pharma B.V. officially notified … -
List item
Human medicine European public assessment report (EPAR): Lamivudine Teva (updated)
lamivudine, Hepatitis B, Chronic
Date of authorisation: 23/10/2009,
, Revision: 10, Authorised, Last updated: 26/02/2021
Lamivudine Teva Hepatitis B, Chronic … report (EPAR) for Lamivudine Teva. It explains how the Committee … conditions of use for Lamivudine Teva. What is Lamivudine Teva? Lamivudine Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Teva (updated)
levetiracetam, Epilepsy
Date of authorisation: 25/08/2011,, Revision: 16, Authorised, Last updated: 02/02/2021
Levetiracetam Teva Epilepsy … Levetiracetam Teva … the public Levetiracetam Teva levetiracetam This is … -
List item
Human medicine European public assessment report (EPAR): Imatinib Teva
imatinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Hypereosinophilic Syndrome, Dermatofibrosarcoma
Date of authorisation: 07/01/2013,, Revision: 15, Authorised, Last updated: 29/01/2021
Imatinib Teva Leukemia, Myelogenous, Chronic … Imatinib Teva … Imatinib Teva, INN-imatinib 30 Churchill … -
List item
Human medicine European public assessment report (EPAR): Ribavirin Teva
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 31/03/2009,, Revision: 14, Authorised, Last updated: 23/11/2020
Ribavirin Teva Hepatitis C, Chronic … Ribavirin Teva … seven medicines (Cilazapril Teva, Fenofibrato Pensa, Fenofibrato … -
List item
Human medicine European public assessment report (EPAR): Docetaxel Teva
docetaxel, Head and Neck Neoplasms, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma, Prostatic Neoplasms, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 26/01/2010,, Revision: 18, Authorised, Last updated: 23/11/2020
Docetaxel Teva Head and Neck Neoplasms Carcinoma … Docetaxel Teva … EU/1/09/611/001 Docetaxel TEVA 20 mg /0.72 ml Concentrate … -
List item
Human medicine European public assessment report (EPAR): Sildenafil Teva
sildenafil, Erectile Dysfunction
Date of authorisation: 30/11/2009,, Revision: 15, Authorised, Last updated: 13/10/2020
Sildenafil Teva Erectile Dysfunction … Sildenafil Teva … Sildenafil Teva, INN-sildenafil 7 … -
List item
Human medicine European public assessment report (EPAR): Tevagrastim
filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 15/09/2008,
, Revision: 13, Authorised, Last updated: 19/10/2020
Tevagrastim Neutropenia Hematopoietic … Tevagrastim … ASSESSMENT REPORT (EPAR) TEVAGRASTIM EPAR summary for the public … -
List item
Human medicine European public assessment report (EPAR): Desloratadine Teva
desloratadine, Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Seasonal
Date of authorisation: 24/11/2011,, Revision: 15, Authorised, Last updated: 16/09/2020
Desloratadine Teva Rhinitis, Allergic, Perennial Rhinitis … Desloratadine Teva … the public Desloratadine Teva desloratadine This is … -
List item
Human medicine European public assessment report (EPAR): Temozolomide Teva
temozolomide, Glioma, Glioblastoma
Date of authorisation: 28/01/2010,, Revision: 19, Authorised, Last updated: 10/07/2020
Temozolomide Teva Glioma Glioblastoma … Temozolomide Teva … Temozolomide Teva, INN: temozolomide EMA/523990/2014 … -
List item
Human medicine European public assessment report (EPAR): Capecitabine Teva
capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012,
, , Revision: 13, Authorised, Last updated: 29/07/2020
Capecitabine Teva Colonic Neoplasms Breast … Capecitabine Teva … Assessment report Capecitabine Teva International non-proprietary … -
List item
Human medicine European public assessment report (EPAR): Olanzapine Teva
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 12/12/2007,, Revision: 27, Authorised, Last updated: 27/05/2020
Olanzapine Teva Schizophrenia Bipolar Disor … Olanzapine Teva … Olanzapine Teva, INN-olanzapine 7 … -
List item
Human medicine European public assessment report (EPAR): Irbesartan Teva
irbesartan, Hypertension
Date of authorisation: 30/10/2009,, Revision: 12, Authorised, Last updated: 10/12/2019
Irbesartan Teva Hypertension … Irbesartan Teva … Irbesartan Teva irbesartan irbesartan … -
List item
Human medicine European public assessment report (EPAR): Efavirenz Teva
efavirenz, HIV Infections
Date of authorisation: 09/01/2012,, Revision: 9, Authorised, Last updated: 17/10/2019
Efavirenz Teva HIV Infections … Efavirenz Teva … for the public Efavirenz Teva efavirenz This is a summary … -
List item
Human medicine European public assessment report (EPAR): Nevirapine Teva
nevirapine, HIV Infections
Date of authorisation: 30/11/2009,, Revision: 9, Authorised, Last updated: 22/08/2019
Nevirapine Teva HIV Infections … Nevirapine Teva … quot;Nevirapin Teva, INN-nevirapin" EMA/524629/2014 … -
List item
Human medicine European public assessment report (EPAR): Cabazitaxel Teva
cabazitaxel, Prostatic Neoplasms
Date of refusal: 11/07/2019, Refused, Last updated: 24/07/2019Cabazitaxel Teva Prostatic Neoplasms … Cabazitaxel Teva … Cabazitaxel Teva cabazitaxel cabazitaxel … -
List item
Human medicine European public assessment report (EPAR): Entacapone Teva
entacapone, Parkinson Disease
Date of authorisation: 18/02/2011,, Revision: 8, Authorised, Last updated: 13/12/2018
Entacapone Teva Parkinson Disease … Entacapone Teva … Entacapone Teva-INN-Entacapone HCl 30 Churchill Place … -
List item
Human medicine European public assessment report (EPAR): Telmisartan Teva
telmisartan, Hypertension
Date of authorisation: 25/01/2010,, Revision: 10, Authorised, Last updated: 05/09/2018
Telmisartan Teva Hypertension … Telmisartan Teva … Telmisartan Teva telmisartan telmisartan … -
List item
Human medicine European public assessment report (EPAR): Topotecan Teva
topotecan, Ovarian Neoplasms, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 21/09/2009,, Revision: 8, Withdrawn, Last updated: 13/07/2018
Topotecan Teva Ovarian Neoplasms Uterine … Topotecan Teva … EMEA/H/C/1071 Topotecan Teva topotecan EPAR summary … -
List item
Human medicine European public assessment report (EPAR): Repaglinide Teva
repaglinide, Diabetes Mellitus, Type 2
Date of authorisation: 28/06/2009,, Revision: 7, Authorised, Last updated: 04/10/2016
Repaglinide Teva Diabetes Mellitus, Type 2 … Repaglinide Teva … EMEA/H/C/ 1067 Repaglinide Teva repaglinide EPAR summary … -
List item
Human medicine European public assessment report (EPAR): Leflunomide Teva
leflunomide, Arthritis, Rheumatoid
Date of authorisation: 10/03/2011,, Revision: 6, Withdrawn, Last updated: 18/03/2014
Leflunomide Teva Arthritis, Rheumatoid … Leflunomide Teva … Public statement Leflunomide Teva Cessation of validity of … -
List item
Human medicine European public assessment report (EPAR): Rivastigmine Teva
rivastigmine, Dementia, Alzheimer Disease, Parkinson Disease
Date of authorisation: 17/04/2009,, Revision: 4, Withdrawn, Last updated: 27/09/2012
Rivastigmine Teva Dementia Alzheimer Disease Parkinson … Rivastigmine Teva … Rivastigmine Teva, INN-rivastigmine 7 … -
List item
Human medicine European public assessment report (EPAR): Raloxifene Teva (updated)
raloxifene hydrochloride, Osteoporosis, Postmenopausal
Date of authorisation: 29/04/2010,, Revision: 9, Authorised, Last updated: 03/02/2021
Raloxifene Teva Osteoporosis, Postmenopausal … Report (EPAR) for Raloxifene Teva. It explains how the Committee … conditions of use for Raloxifene Teva. What is Raloxifene Teva? Raloxifene Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Telmisartan Teva Pharma
telmisartan, Hypertension
Date of authorisation: 03/10/2011,, Revision: 9, Authorised, Last updated: 28/01/2021
Telmisartan Teva Pharma Hypertension … report (EPAR) for Telmisartan Teva Pharma. It explains how the … conditions of use for Telmisartan Teva Pharma. What is Telmisartan Teva Pharma? Telmisartan Teva Pharma is a medicine that …